16-year follow-up of the Danish Acute Myocardial Infarction 2 (DANAMI-2) trial: primary percutaneous coronary intervention vs. fibrinolysis in ST-segment elevation myocardial infarction

Pernille G Thrane, Steen D Kristensen, Kevin K W Olesen, Leif S Mortensen, Hans Erik Bøtker, Leif Thuesen, Henrik S Hansen, Ulrik Abildgaard, Thomas Engstrøm, Henning R Andersen, Michael Maeng

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

7 Citationer (Scopus)
OriginalsprogEngelsk
TidsskriftEuropean Heart Journal
Vol/bind41
Udgave nummer7
Sider (fra-til)847-854
Antal sider8
ISSN0195-668X
DOI
StatusUdgivet - 14 feb. 2020

Bibliografisk note

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.

Fingeraftryk Dyk ned i forskningsemnerne om '16-year follow-up of the Danish Acute Myocardial Infarction 2 (DANAMI-2) trial: primary percutaneous coronary intervention vs. fibrinolysis in ST-segment elevation myocardial infarction'. Sammen danner de et unikt fingeraftryk.

  • Citationsformater

    Thrane, P. G., Kristensen, S. D., Olesen, K. K. W., Mortensen, L. S., Bøtker, H. E., Thuesen, L., Hansen, H. S., Abildgaard, U., Engstrøm, T., Andersen, H. R., & Maeng, M. (2020). 16-year follow-up of the Danish Acute Myocardial Infarction 2 (DANAMI-2) trial: primary percutaneous coronary intervention vs. fibrinolysis in ST-segment elevation myocardial infarction. European Heart Journal, 41(7), 847-854. https://doi.org/10.1093/eurheartj/ehz595